Search
Search Results
##search.searchResults.foundPlural##
-
PROPHYLAXIS OF MALARIA
2967PDF: 998HTML: 17777Figures SChwartz: 150 -
-
PROGNOSTIC FACTORS IN HODGKIN LYMPHOMA
3221PDF: 1924HTML: 7456 -
GILTERITINIB (XOSPATA ®) IN TURKEY: EARLY ACCESS PROGRAM RESULTS Gilteritinib (XOSPATA ®) in Turkey
1300PDF: 878Suppl. Files: 435HTML: 220 -
SIMILARITIES OF ELDERLY AND THERAPY-RELATED AML
3525PDF: 850HTML: 6698 -
TP53-MUTATED MYELODYSPLASIA AND ACUTE MYELOID LEUKEMIA TP53 in MDS and AML
2007PDF: 1614HTML: 347 -
CMV IN HEMATOPOIETIC STEM CELL TRANSPLANTATION
4729PDF: 1725HTML: 2690Untitled: 197 -
TREATMENT OF ADVANCED SYSTEMIC MASTOCYTOSIS WITH MIDOSTAURIN: PRACTICAL GUIDANCE FOR OPTIMAL THERAPY AND MANAGEMENT Advanced systemic mastocytosis and midostaurin
1190PDF: 942HTML: 192 -
THROMBOCYTOPENIA IN PATIENTS WITH CHRONIC HEPATITIS C VIRUS INFECTION
4003PDF: 1888HTML: 1749 -
THE HISTORY OF DEFERIPRONE (L1) AND THE COMPLETE TREATMENT OF IRON OVERLOAD IN THALASSAEMIA The history and roles of deferiprone
2287PDF: 1554HTML: 587 -
FROM LEGACY TO INNOVATION: PIDOTIMOD’S EXPANDING THERAPEUTIC HORIZON Pidotimod: Revisiting a Classic Immunomodulator
2142PDF: 869HTML: 320 -
EFFICACY AND SAFETY OF SINOPHARM VACCINE FOR SARS-COV-2 AND BREAKTHROUGH INFECTIONS IN IRANIAN PATIENTS WITH HEMOGLOBINOPATHIES: A PRELIMINARY REPORT Sinopharm Vaccination in Iranian Patients with Hemoglobinopathies
1469PDF: 696HTML: 216 -
NEW THERAPEUTIC OPTIONS FOR THE TREATMENT OF SICKLE CELL DISEASE Guest Editor: Raffaella Origa
6724PDF: 3590HTML: 733 -
CLONAL HEMATOPOIESIS: ROLE IN HEMATOLOGIC NON-HEMATOLOGIC MALIGNANCIES CLONAL HEMATOPOIESIS AND MALIGNANCIES
1912PDF: 845HTML: 1318 -
HIV INFECTION, ANTIRETROVIRAL THERAPY AND CARDIOVASCULAR RISK
1776PDF: 780HTML: 3584 -
NOVEL AGENTS AND EMERGING STRATEGIES FOR TARGETING THE B-CELL RECEPTOR PATHWAY IN CLL
2451PDF: 823HTML: 8794Efremov 1: 208Efremov 2: 170 -
CAR-T CELL THERAPY IN B-CELL ACUTE LYMPHOBLASTIC LEUKEMIA CAR-T CELL and B-ALL
3857PDF: 3170HTML: 187 -
VITAMIN D STATUS IN THALASSEMIA MAJOR: AN UPDATE
2615PDF: 1049HTML: 2544 -
SYSTEMIC MASTOCYTOSIS: MULTIDISCIPLINARY APPROACH Systemic Mastocytosis
1450PDF: 903HTML: 210 -
TREATMENT RECOMMENDATIONS FOR CHRONIC MYELOID LEUKEMIA
3244PDF: 1433HTML: 3985 -
CURRENT ISSUES AND OPTIONS FOR HORMONAL CONTRACEPTION IN ADOLESCENTS AND YOUNG ADULT WOMEN WITH SICKLE CELL DISEASE: AN UPDATE FOR HEALTH CARE PROFESSIONALS Hormonal Contraception in Adolescents and Young Adult Women With Sickle Cell Disease
2090PDF: 1389HTML: 683 -
Improving BNT162b2 mRNA vaccine tolerability without efficacy loss by Pidotimod supplementation Pidotimod in SARS-CoV-2 vaccination
1055PDF: 527HTML: 208 -
-
THE ROLE OF INFECTION IN THE PATHOGENESIS OF VASO-OCCLUSIVE CRISIS IN PATIENTS WITH SICKLE CELL DISEASE.
5076PDF: 1296HTML: 2729Cover letter: 179 -
NEW TREATMENTS FOR MYELODYSPLASTIC SYNDROMES
1892PDF: 720HTML: 681 -
CENTRAL NERVOUS SYSTEM INVOLVEMENT IN ADULT ACUTE LYMPHOBLASTIC LEUKEMIA: DIAGNOSTIC TOOLS, PROPHYLAXIS AND THERAPY
3983PDF: 1900HTML: 5200Table 1: 174 -
ADVERSE PREGNANCY OUTCOMES IN SICKLE CELL TRAIT: A PROSPECTIVE COHORT STUDY EVALUATING CLINICAL AND HAEMATOLOGICAL PARAMETERS IN POSTPARTUM MOTHERS AND NEW-BORNS. Sickle cell trait pregnancy and outcomes
1291PDF: 1180HTML: 446







